Search hospitals

>

Virginia

>

Norfolk

Children's Hospital of The King's Daughters

Claim this profile

Norfolk, Virginia 23507

Global Leader in Brain Tumor

Global Leader in Cancer

Conducts research for Neuroblastoma

Conducts research for Soft Tissue Sarcoma

Conducts research for Solid Tumors

316 reported clinical trials

8 medical researchers

Photo of Children's Hospital of The King's Daughters in NorfolkPhoto of Children's Hospital of The King's Daughters in NorfolkPhoto of Children's Hospital of The King's Daughters in Norfolk

Summary

Children's Hospital of The King's Daughters is a medical facility located in Norfolk, Virginia. This center is recognized for care of Brain Tumor, Cancer, Neuroblastoma, Soft Tissue Sarcoma, Solid Tumors and other specialties. Children's Hospital of The King's Daughters is involved with conducting 316 clinical trials across 502 conditions. There are 8 research doctors associated with this hospital, such as Eric Lowe, MD, Crystal Proud, MD, Michael Strunc, M.D., and Sameer Lapsia.

Area of expertise

1

Brain Tumor

Global Leader

Children's Hospital of The King's Daughters has run 51 trials for Brain Tumor. Some of their research focus areas include:

Stage I
Stage II
Stage IV
2

Cancer

Global Leader

Children's Hospital of The King's Daughters has run 48 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital of The King's Daughters

Brain Tumor

Testicular cancer

Duchenne Muscular Dystrophy

Wilms Tumor

Leukemia

Burkitt Lymphoma

Acute Lymphoblastic Leukemia

Langerhans Cell Histiocytosis

Cancer

Acute Myeloid Leukemia

Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital of The King's Daughters?

Where is Children's Hospital of The King's Daughters located?

Who should I call to ask about financial aid or insurance network?

What insurance does Children's Hospital of The King's Daughters accept?

What awards or recognition has Children's Hospital of The King's Daughters received?